SABCS 2014: SOFT Trial Commentary by Dr. Sunil Verma: Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Analysis of the SOFT trial
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content